The COVID-19 pandemic caused severe drug shortages and made illicit drugs deadlier, exposing deep flaws in healthcare and supply systems. Millions faced access issues, while overdose deaths soared.
READ MORE
Drug shortages are rising because supply chains are too fragile. Learn how building resilience - through diversification, buffer stocks, and visibility - can prevent life-threatening gaps in medicine access.
READ MORE